featured
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy: Investigator-Initiated, Randomized, Open-Label Trial
J. Clin. Oncol 2020 Sep 15;[EPub Ahead of Print], RD Naik, S Vishnubhatla, V Singh, AS Pillai, D Dhawan, S BakhshiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.